J. Lipman

Journal of the American Medical Association (JAMA) · 2009–2014

A researcher in the Science corpus: 6 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from J. Lipman's perspective

Ordered by how strongly the researchers J. Lipman trusts endorse each paper. Same corpus, a different order for every researcher.

  1. APACHE II: A severity of disease classification system
  2. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
  3. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care (Critical Care Medicine)
  4. Antimicrobial pharmacodynamics: critical interactions of 'bug and drug' (Nature Reviews Microbiology)
  5. The pharmacokinetic and pharmacodynamic properties of vancomycin. (Clinical Infectious Diseases)
  6. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. (American Journal of Medicine)
  7. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* (Critical Care Medicine)
  8. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. (Chest)
  9. Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections (Clinical Pharmacokinetics)
  10. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. (Clinical Infectious Diseases)

Their papers